AMGC Commercialisation Fund

AMGC Commercialisation Fund Program

What is the AMGC Commercialisation Fund?

The AMGC Commercialisation Fund is a grant opportunity to support Australian companies to commercialise new products and processes based upon already existing or new IP. The Commercialisation Fund is intended to fund later stage commercialisation, not early-stage research based programs. However, projects are still encouraged to include collaboration with research partners.



The Advanced Manufacturing Growth Centre (AMGC) was established in 2015 as a key plank of the Australian Government’s Industry Growth Centre Initiative. Its goal is to drive innovation, productivity and competitiveness across Australia’s manufacturing industry.

AMGC is an industry-led, not-for-profit organisation and is run by a board and management team of industry experts. It is connected with a nationwide network of manufacturers, universities and research institutions, and export hubs.



The objectives of the grant are to fund projects through AMGC’s Commercialisation Fund that:

  • Commercialise new products and processes within the Australian manufacturing industry that are at the TRL 6 to 9.
  • Invest in Australian manufacturing projects that aim to transition a new product or process from the pilot/ prototype stage to full commercial operations.

The intended outcomes of the AMGC Commercialisation Fund are:

  • To increase the capability and competitiveness of Australian manufacturers under the six National Manufacturing Priorities: Food and Beverage; Medical Products; Resources Technology and Critical Minerals processing; Recycling and Clean Energy; Defence; and Space, through the implementation of new technologies
  • To increase productivity and create jobs in the Australian manufacturing industry



For this grant opportunity $30 million is available from 2020-21 to 2022-23.

The grant amount will be up to 50 per cent of eligible project expenditure (grant percentage).

  • The minimum grant amount is $100,000, and
  • The maximum grant amount is $1,000,000

Grantees will contribute a minimum of 50% of eligible project costs as cash contributions. Grantees cannot fund their contribution from other Commonwealth, State, Territory or local government grant source, or use in-kind (non-financial) contributions to match Commonwealth funding. Grantees must provide evidence of their ability to fund their contribution in their application.


Eligible Projects

Australian manufacturing industry projects funded through the AMGC Commercialisation Fund may include the following activities:

  • Collaboration and networking with other businesses to develop a product and establish market potential.
  • Collaborating with research and technology hubs/centres to test ideas and share knowledge.
  • Engaging external professionals to provide commercialisation and market advice, such as identifying market opportunities and developing a market strategy.
  • Creating distribution strategies, such as market entry pathway and identifying domestic supply chains.
  • Developing a product for commercialisation using high value manufacturing techniques or processes such as rapid prototyping or using state-of-the-art manufacturing plant.
  • Acquiring, constructing, installing and commissioning of new machinery and equipment to facilitate the project (limited to 25% of grant funding)
  • Research collaboration as it relates to the validation/viability of later stage commercialisation, and
  • Approved production and post-production manufacturing activities related to commercialisation.

The intended outcomes of the AMGC Commercialisation Fund are to increase the capability and competitiveness of Australian manufacturers under the six National Manufacturing Priorities through the implementation of new technologies; and to increase productivity and create jobs in the Australian manufacturing industry. In undertaking the Activity, the Grantee must comply with the requirements of the grant opportunity guidelines (as in force at the time of application).


Eligible Applicants

To be eligible for the AMGC Commercialisation Fund you must:

  • Have an Australian Company Number (ACN)
  • Have an Australian Business Number (ABN)
  • Be non-tax-exempt
  • Be registered for the Goods and Services Tax (GST)
  • and be an entity incorporated in Australia, including start-ups and a trading corporation, where your trading activities form a sufficiently significant proportion of the corporation’s overall activities as to merit it being described as a trading corporation or are a substantial and not merely peripheral activity of the corporation.

AMGC Commercialisation Fund can only accept applications:

  • From manufacturing small and medium-sized Australian enterprises (SMEs) with up to 199 employees (headcount) however larger organisations are eligible to apply and may be accepted due to the impact on Australian manufacturing generally
  • With a minimum of $200,000 in eligible project expenditure
  • Where your application clearly identifies the level of job creation in Australia expected from your project
  • Where your project aligns with one or more of the six National Manufacturing Priorities
  • Where you can provide evidence that you can complete the project and meet the costs of the project not covered by grant funding.
  • Where you can provide evidence of how you will provide your share of project costs using the accountant declaration template which confirms you can fund your share of the project costs, including any ineligible expenditure. The accountant declaration template must be used and is available on
  • From an AMGC member. AMGC membership is open to all industry partners and is free.
  • Where the project has at minimum three project collaborators.



Applications close 30 June 2022.


Latest Recipients


  • Allthread Industries (NSW) – Recycling and Clean Energy – Develop and automate a new thermal arc spray line to manufacture corrosion-resistant structural fasteners, which offer superior value and environmental performance when compared to imported hot-dipped galvanised fasteners. Total project commitment $8.86 million ($367,860 from Commercialisation Fund)
  • Plantabl (VIC) – Recycling and Clean Energy – Commercialisation and manufacture of Great Wrap’s biopolymer resin (cling wrap) derived from organic waste, to produce a compostable stretch wrap that can replace plastic cling, silage, and pallet wraps. Total project commitment $6.41 million ($534,760 from Commercialisation Fund)
  • 3RT (VIC) – Recycling and Clean Energy – Development of large-scale manufacturing capability for 3RT’s innovative and patented technology which converts low-value wood residue into a new hardwood with the same properties as 100-year-old timber. Total project commitment $3,326,840 ($698,420 from Commercialisation Fund)
  • Sustinent (NSW) – Recycling and Clean Energy – Commercialisation of a scalable process utilising sugarcane waste to make value-add products such as mushroom grow bags. Once implemented, the Sustinent process will also be able to address problematic waste from cotton, rice, or wheat crops. Total project commitment $2.94 million ($499,500 from Commercialisation Fund)
  • Endua (QLD) – Recycling and Clean Energy – Development of onshore manufacturing capability for affordable hydrogen power banks that will deliver 100% renewable energy, on demand, as electricity. Total project commitment $2.28 million ($948,240 from Commercialisation Fund)
  • Solar Analytics (NSW) – Recycling and Clean Energy – Manufacturer of SolarConnect product to manage energy generation and consumption from rooftop solar, inverters and batteries to achieve maximum benefit from rooftop solar systems. Total project commitment $1.44 million ($500,000 from Commercialisation Fund)
  • Venlo (QLD) – Recycling and Clean Energy – Manufacture of a100% recycled, repairable pallet, managed within a circular & closed-loop automated repair and remanufacturing system that is tracked/traced and serviced within a global network driving critical continual improvement in safety, security, providence and cost reduction outcomes. Total project commitment $710,900 ($450,000 from Commercialisation Fund)
  • Geofabrics (NSW) – Recycling and Clean Energy – Integration of recycled materials into Geofabrics’ new and improved drainage products for infrastructure sector via a purpose-built manufacturing process to meet market demand for circular recycling solutions. Total project commitment $607,000 ($252,000 from Commercialisation Fund)
  • TomKat Global (QLD) – Recycling and Clean Energy – Manufacture of a new thermal container for the transportation of temperature sensitive and perishable produce. The KoolPak has superior thermal performance to a polystyrene container, it is multi-use, fully traceable and recyclable. Total project commitment $555,000 ($267,500 from Commercialisation Fund)
  • YOUC (VIC) – Recycling and Clean Energy – Commercialisation of a new ‘Smart Box’ system which will enable the tracking and tracing of boxes through the manufacturing process allowing for real-time restocking, reordering and waste reduction. Total project commitment $710,900 ($297,500 from Commercialisation Fund)


  • Ceramisphere (NSW) – Medical Products – Development of a manufacturing capability of transdermal (skin) drug delivery system using its unique nanocomposite patch technology for pain relief. Total project commitment $2.17 million ($471,000 from Commercialisation Fund)
  • Elenium (VIC) – Medical Products – Develop a biometric device that can be deployed into a range of environments to automate biometric identification for access control, ticketing, contact tracing (requiring Government integration), vaccination and antigen test status, and the capability to perform contactless fever detection once approved. Total project commitment $1.35 million ($553,364 from Commercialisation Fund)
  • Examin (QLD) – Medical Products – Commercialisation of a 2-minute COVID-19 breath test using a novel electrochemical biosensor that detects viral load at a molecular level with a sensitivity and specificity of 97%-98%. Total project commitment $1.3 million ($647,665 from Commercialisation Fund)
  • Vaxxas (QLD) – Medical Products – Scaling and automation of manufacturing capability to produce a novel, needle-free vaccination platform. The High-Density Micro-projection Array Patch (HD-MAP) aims to improve the efficacy, reach, safety and economics of vaccination. Total project commitment $1.59 million ($600,000 from Commercialisation Fund)
  • Minomic Int (NSW) – Medical Products – Commercialisation of the MiCheck® Prostate test that is designed to detect life threatening aggressive prostate cancer in its early stages.  MiCheck® Prostate overcomes the low accuracy of conventional screening tests to reduce unnecessary intervention such as painful biopsies and improve overall management of the patient.Total project commitment $793,856 ($396,928 from Commercialisation Fund)
  • Reid Print Technologies (QLD) – Medical Products – Field trials and commercial certification of a novel ‘Smart Shoe Insole’ (Smart Orthotics Sensor Skin), used to monitor the onset of foot ulcers that commonly afflict diabetes sufferers. Total project commitment $690,000 ($300,000 from Commercialisation Fund)


  • TPS (QLD) – Food and Beverage – Commercialisation of advanced digital sensors for testing of water quality parameters in the food and beverage sector. Total project commitment $1.31 million ($444,875 from Commercialisation Fund)
  • ICEE (VIC) – Food and Beverage – Commercialisation of Bouncee, a reusable and collapsible insulated crate and coolant system for short transit perishable logistics, such as click and collect, and home delivery. Total project commitment $1.31 million ($444,875 from Commercialisation Fund)


  • Premcar (VIC) – Defence – Development of a manufacturing program to support the installation of a new, latest-technology, powertrain into land-based defence vehicles for local and export applications. Total project commitment $1.53 million ($699,931 from Commercialisation Fund)
  • Microbio (QLD) – Defence – Establish sovereign manufacturing of Microbio’s unique InfectID PCR testing technology that provides rapid, highly sensitive bacterial, fungal, and viral pathogen identification in clinical samples for defence and civilian use. Total project commitment $1.11 million ($407,119 from Commercialisation Fund)


  • EQ Resources (VIC) – Resource Technology and Critical Mineral Processing – Commercialisation and scaling of EQ Resources’ large-scale x-ray (XRT) and hyperspectral imaging (HIS) sensors for front-end loaders enabling the sorting of tungsten from historic mine waste stockpiles. Total project commitment $2.17 million ($471,000 from Commercialisation Fund)
  • Technofast (QLD) – Resource Technology and Critical Mineral Processing – Commercialisation of Technofast’s Hydraulic Head Nut, which replaces original retaining nuts used to fasten the conical “mantle” in massive gyratory ore crushers. Because crushers are subject to rapid wear and need regular replacement, the new fasteners allow for rapid replacement and maintenance, thereby reducing machine downtime and increasing operational safety for workers. Total project commitment $518,970 ($259,485 from Commercialisation Fund)


  • Spiral Blue (NSW) – Space – Commercialisation of Rainbow Python: a world-first integrated hyperspectral instrument and onboard computer that allows for the chemical analysis of any location on earth from space for use in agriculture, forestry, mining, and other sectors. Total project commitment $2.97 million ($578,000 from Commercialisation Fund)
  • Black Sky Aero (QLD) – Space – Establish sovereign manufacture of vital precursor materials for solid rocket propellant not currently produced in Australia. This will lead to significant domestic and export market opportunities. Total project commitment $1.1 million ($497,750 from Commercialisation Fund)


More Information


Latest News

03 February 2022 – 24 Australian manufacturers to commercialise world-leading products

Australian manufacturers continue to drive Australia’s economic recovery from the pandemic. With the latest round of co-investment awarded to local manufacturers, these projects are commercialising better ways to manage and mitigate our health and security concerns, improve food and beverage operations, and make better use of our planet and its finite resources.

The latest round of 24 co-invested projects announced via the Advanced Manufacturing Growth Centre managed Commercialisation Fund will see Australia’s manufacturing industry contribute over $32.4 million in funding alongside the Federal Government’s $9.03 million to drive commercialisation of world-leading Australian-made products. With $29 million of the $30 million Commercialisation Fund allocated to 55 projects just 10-months after the launch of the program, AMGC can reveal that the spread of projects across the six National Manufacturing Priorities, with:

  • 34 per cent of projects spanning the NMP of Recycling and Clean Energy
  • 23 per cent of projects spanning the NMP of Medical Product
  • 18 per cent of projects spanning the NMP of Food and Beverage
  • 11 per cent of projects spanning the NMP of Resource Technology and Critical Mineral Processing

While the remaining 14 per cent is split equitably between the NMPs of Space and Defence. All 24 co-invested projects from tranches 6, 7 and 8 are expected to create a substantial number of local jobs while driving additional revenues and export opportunities for the locally manufactured products.


07 October 2021 – Ellen Medical Devices receives $427,500

Sydney-based start-up Ellen Medical Devices will receive $427,500 in government funding that will be matched by the company, making a total investment of $1.04 million to develop its award-winning Ellen Medical Dialysis System.

The investment is part of the Advanced Manufacturing Growth Centre’s (AMGC) $30 million Commercialisation Fund supporting innovative Australian businesses to grow their manufacturing capabilities and commercialise world-leading products.

Ellen Medical Managing Director and kidney specialist Professor John Knight said that global epidemics of high blood pressure, obesity and diabetes, were leading to rapidly rising rates of kidney disease.

07 October 2021 – Grants to help manufacturers commercialise great ideas

Ten successful projects will share in more than $5.7 million in funding to scale up their operations and bring their products to market. Acting Minister for Industry, Science and Technology Angus Taylor says the projects are a testament to the ingenuity of Australia’s manufacturing sector.

The projects funded under tranches four and five of the Commercialisation Fund include:

  • Sleeptite PTY LTD (Hawthorn, VIC) has received $872,004 to fast-track the development of its revolutionary “REMI” sleep technology – a mattress monitoring and alert system for use in medical and care settings, providing real-time data analysis of a patient’s presence, position and posture while they are in bed.
  • Commonwealth Steel Company Pty Limited (Molycop) (Sydney, NSW) has received $750,000 to develop its solution to transform Australian steel manufacturing. By recycling tyres, conveyer belts and gumboots to generate carbon and hydrogen, and incorporating these into the steel manufacturing process, Molycop is helping the steel manufacturing industry to reduce its carbon footprint and improve sustainability and productivity.
  • Nexxis Technology Pty Ltd (O’Connor, WA) has received $675,002 to continue the development of its Magneto Modular Deployment Platform, a multi-limbed, climbing inspection robot which can provide testing and measuring for a variety of applications including oil rigs, engines, machinery, mining operations, infrastructure projects and manufacturing processes.
  • Ellen Medical Devices Pty Limited (Newtown, NSW) has received $427,500 to manufacture and certify an affordable portable peritoneal dialysis system for sufferers of kidney failure, and develop a competitive manufacturing facility in Australia with significant export potential.
  • Savic Motorcycles Pty Limited (West Melbourne, VIC) has received $657,481 to complete the development of its Australian-first, high-performance electric motorcycle to roadworthy certification.
  • Sea Forest Ltd (Tasmania) received $675,000 to help it establish a processing and manufacturing facility for its seaweed product that could help Australia’s farmers to significantly reduce their carbon footprint. 

20 July 2021 – Government dishes out $7m in commercialisation grants 

The federal government has handed 15 Australian manufacturers a total of $7.1 million to help their commercialised products, with New South Wales projects accounting for nearly half the initiatives funded.

Projects received the grants of up to $1 million on a co-funding basis, with government funding to make up no more than half of total project costs, and must fall within one of the government’s six priority areas of manufacturing.

Recipients include ultra-efficient heating and cooling systems, fuel cells, brain injury assessment device and portable x-ray technology.


04 May 2021 – NT Government, AMGC Announce $8.75M “Kickstarter On Steroids”

The federally-funded Advanced Manufacturing Growth Centre and the Northern Territory government have announced a partnership, which will see the NT government invest $8.75 million over five years to back commercialisation projects.

The funding would “fast-track innovation projects and generate millions of dollars in co-investment” according to a statement.

The announcement includes project grant funding, as well as:

  •       A permanent AMGC Territory director appointed “to build connections between local manufacturers and interstate research institutions” and
  •       Establishment of an AMGC office in Darwin for that director, with support from AMGC’s existing national team.

As with federal-level AMGC projects, grant funding would support collaborative projects with the lead manufacturer having to invest at least a dollar of their own money to receive a dollar of grant support.


Leave a Comment

Scroll to Top
R&D Top 10 Consultant Tips

Top 10 Consultant Tips to Maximise the R&D Tax Incentive